BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21528644)

  • 1. Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.
    Cizmeciolu M; Pabuguoglu V; Ballar P; Pabuççuoğlu A; Soyer Z
    Arzneimittelforschung; 2011; 61(3):186-90. PubMed ID: 21528644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity.
    Zarghi A; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2007 Jan; 15(2):1056-61. PubMed ID: 17067801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
    Handler N; Jaeger W; Kuen-Krismer B; Erker T
    Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors.
    Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
    Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
    J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of disubstituted 4,5-polymethylenepyrazoles as selective cyclooxygenase-2 inhibitors.
    Yu JW; Kim HH; Jahng Y
    Pharmazie; 2002 May; 57(5):301-5. PubMed ID: 12061251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
    Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
    Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic acid: a new lead compound with selective COX-2 inhibitory activity.
    Abdel-Rahman HM; Ozadali K
    Arch Pharm (Weinheim); 2012 Nov; 345(11):878-83. PubMed ID: 22907715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide and its analogues as cyclooxygenase inhibitors.
    Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1043-6. PubMed ID: 11909713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-phenylphthalimide-type cyclooxygenase (COX) inhibitors derived from thalidomide: substituent effects on subtype selectivity.
    Sano H; Noguchi T; Tanatani A; Miyachi H; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):1021-2. PubMed ID: 15305008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
    Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
    Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
    Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
    Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and biological evaluation of indole-2 and 3-carboxamides: new selective cyclooxygenase-2 inhibitors.
    Olgen S; Güner E; Fabregat MA; Crespo MI; Nebioğlu D
    Pharmazie; 2002 Apr; 57(4):238-42. PubMed ID: 11998441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation.
    Kaur J; Bhardwaj A; Huang Z; Knaus EE
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2154-9. PubMed ID: 22361134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
    Ghodsi R; Zarghi A; Daraei B; Hedayati M
    Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.